With over 100 years of pharmaceutical industry heritage behind it, EVA Pharma has expanded rapidly in recent years, with a CAGR of 24.39 percent over the last three years, propelling the firm to second place in the overall Egyptian pharma market. CEO Riad Armanious explains why EVA Pharma is intensifying its innovative footprint – its Mounir Armanious Research Center (MARC) is now the largest dedicated site for pharmaceutical development and services in the MENA region –, outlines the exciting transformation underway within Egyptian healthcare, and talks about making EVA Pharma a ‘pan-African’ pharma champion.
At EVA Pharma, we are trying to be a pan-African company and, while we already have a presence in Western Europe and the Middle East, we see the biggest opportunity in Africa.
